N-乙酰基-L-亮氨酰基-L-亮氨酰基-L-正亮氨酸醛
MG-101
产品编号.: | A044821 | CAS号: | 110044-82-1 |
分子式: | C20H37N3O4 | 分子量: | 383.52548 |
纯度: | 98% | MDL NO.: |
中文名称:N-乙酰基-L-亮氨酰基-L-亮氨酰基-L-正亮氨酸醛
CAS号:110044-82-1
中文别名:N-乙酰基-L-亮氨酰-N-[(1S)-1-甲酰基戊基]-L-亮氨酰胺;钙蛋白酶抑制剂I;氰化物测试条;钙蛋白酶抑制剂 I;钙蛋白酶抑制剂I(进口)
英文名称:MG-101
英文别名:L-Leucinamide,N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-;CALPAIN INHIBITOR I;MG 101;MG-101 (ALLN);NULL;Ac-Leu-Leu-Nle-al;AC-LEU-LEU-NLE-CHO;AC-LEU-LEU-NORLEUCINAL;ac-llnl-cho;AC-LL-NORLEUCINAL;ALL;ALLN;ALLN Ac-LLnL-CHO MG-101 N-Acetyl-Leu-Leu-Norleu-al N-Acetyl-L-leucyl-L-leucyl-L-norleucinal;CALPAIN INHIBITOR;Calpain Inhibitor I,ALLN;LLNL;MG-101;N-Acetyl-Leu-Leu-Norleu-al;N-Acetyl-L-leucyl-L-leucyl-L-norleucinal;n-acetyl-leu-leu-norleucinal;N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal;InSolution? ALLN;Calpain Inhibitor I;KBio2_002847;(S)-2-acetamido-4-methyl-N-((S)-4-methyl-1-oxo-1-((S)-1-oxohexan-2-ylamino)pentan-2-yl)pentanamide;KBio2_000279;HY-18964;BCBcMAP01_000098;N-acetyl-L-leucyl-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide;2-[(1-Hydroxyethylidene)amino]-N-{1-hydroxy-4-methyl-1-[(1-oxohexan-2-yl)imino]pentan-2-yl}-4-methylpentanimidic acid;UPCMLD-DP120;HMS1989N21;MG101;CHEMBL304784;N-[N-(N-Acetyl-L-leucyl)-L-leucyl]-L-norleucine, aldehyde deriv.;E78366;N-acetylleucylleucylnorleucinal;Acetylleucyl-leucyl-norleucinal;Bio2_000759;FMYKJLXRRQTBOR-BZSNNMDCSA-N;HMS1791N21;Calpain Inhibitor I, >=97% (TLC), powder;KBioGR_000279;HMS3402N21;ALLN - CAS 110044-82-1;Ac-Leu-Leu-Nle-H;s7386;Ac-Leu-Leu-L-norleucinal;N-Acetyl-L-leucine-L-leucine-L-norleucinal;J-002364;Calpain Inhibitor I, >=97.0% (TLC);MFCD00065505;CHEBI:2423;KBio3_000557;NCGC00161662-01;(2S)-2-acetamido-4-methyl-N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxohexan-2-yl]amino]pentan-2-yl]pentanamide;Bio2_000279;HMS1361N21;N-Acetyl-leucyl-leucyl-norleucinal;N-Ac-Leu-leu-norleucinal;Ac-Leu-Leu-Nle-CHO; ALLN;UPCMLD-DP120:002;AKOS024457579;N-acetyl-L-leucyl-L-leucyl-L-leucinal;IDI1_034029;L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-;Q27096777;CALPAIN IHIBITOR I;CCG-208037;NS00069341;(2S)-2-[(2S)-2-acetamido-4-methylpentanamido]-N-[(1S)-1-formylpentyl]-4-methylpentanamide;KBioSS_000279;DTXSID70911457;ALLN, Ac-LLnL-CHO, MG-101, N-Acetyl-Leu-Leu-Norleu-al, N-Acetyl-L-leucyl-L-leucyl-L-norleucinal;DB07558;KBio3_000558;N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-L-leucinamide;Calpain Inhibitor I, N-Acetyl-Leu-Leu-norleucinal, synthetic;UPCMLD-DP120:001;N-{N-[N-Acetyl-(S)-leucyl]-(S)-leucyl}norleucinal;Calpain inhibitor I;Ac-LLnL-CHO;ALLN;2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE;110044-82-1;NCGC00161662-02;BRD-K35923252-001-01-0;CS-4961;SCHEMBL231491;EX-A3085;NCGC00161662-08;BSPBio_001559;(S)-2-acetamido-N-((S)-1-amino-4-methyl-1-oxopentan-2-yl)-4-methyl-N-((S)-1-oxohexan-2-yl)pentanamide;BDBM50069792;BS-48888;NCGC00161662-03;KBio2_005415;Calpain inhibitor I;n-acetyl-l-leucinyl-l-leucinyl-l-norleucinal;Ac-Leu-Leu-Nle-CHO;(2S)-2-[(2S)-2-ACETAMIDO-4-METHYLPENTANAMIDO]-4-METHYL-N-[(2S)-1-OXOHEXAN-2-YL]PENTANAMIDE;GTPL13381;Ac-LLnL-CHO;N-acetyl-Leu-Leu-norLeu-al;Ac-Leu-leu-nle-al
EINECS:
分子式:C20H37N3O4
分子量:383.52548
CAS号:110044-82-1
中文别名:N-乙酰基-L-亮氨酰-N-[(1S)-1-甲酰基戊基]-L-亮氨酰胺;钙蛋白酶抑制剂I;氰化物测试条;钙蛋白酶抑制剂 I;钙蛋白酶抑制剂I(进口)
英文名称:MG-101
英文别名:L-Leucinamide,N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-;CALPAIN INHIBITOR I;MG 101;MG-101 (ALLN);NULL;Ac-Leu-Leu-Nle-al;AC-LEU-LEU-NLE-CHO;AC-LEU-LEU-NORLEUCINAL;ac-llnl-cho;AC-LL-NORLEUCINAL;ALL;ALLN;ALLN Ac-LLnL-CHO MG-101 N-Acetyl-Leu-Leu-Norleu-al N-Acetyl-L-leucyl-L-leucyl-L-norleucinal;CALPAIN INHIBITOR;Calpain Inhibitor I,ALLN;LLNL;MG-101;N-Acetyl-Leu-Leu-Norleu-al;N-Acetyl-L-leucyl-L-leucyl-L-norleucinal;n-acetyl-leu-leu-norleucinal;N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal;InSolution? ALLN;Calpain Inhibitor I;KBio2_002847;(S)-2-acetamido-4-methyl-N-((S)-4-methyl-1-oxo-1-((S)-1-oxohexan-2-ylamino)pentan-2-yl)pentanamide;KBio2_000279;HY-18964;BCBcMAP01_000098;N-acetyl-L-leucyl-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide;2-[(1-Hydroxyethylidene)amino]-N-{1-hydroxy-4-methyl-1-[(1-oxohexan-2-yl)imino]pentan-2-yl}-4-methylpentanimidic acid;UPCMLD-DP120;HMS1989N21;MG101;CHEMBL304784;N-[N-(N-Acetyl-L-leucyl)-L-leucyl]-L-norleucine, aldehyde deriv.;E78366;N-acetylleucylleucylnorleucinal;Acetylleucyl-leucyl-norleucinal;Bio2_000759;FMYKJLXRRQTBOR-BZSNNMDCSA-N;HMS1791N21;Calpain Inhibitor I, >=97% (TLC), powder;KBioGR_000279;HMS3402N21;ALLN - CAS 110044-82-1;Ac-Leu-Leu-Nle-H;s7386;Ac-Leu-Leu-L-norleucinal;N-Acetyl-L-leucine-L-leucine-L-norleucinal;J-002364;Calpain Inhibitor I, >=97.0% (TLC);MFCD00065505;CHEBI:2423;KBio3_000557;NCGC00161662-01;(2S)-2-acetamido-4-methyl-N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxohexan-2-yl]amino]pentan-2-yl]pentanamide;Bio2_000279;HMS1361N21;N-Acetyl-leucyl-leucyl-norleucinal;N-Ac-Leu-leu-norleucinal;Ac-Leu-Leu-Nle-CHO; ALLN;UPCMLD-DP120:002;AKOS024457579;N-acetyl-L-leucyl-L-leucyl-L-leucinal;IDI1_034029;L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-;Q27096777;CALPAIN IHIBITOR I;CCG-208037;NS00069341;(2S)-2-[(2S)-2-acetamido-4-methylpentanamido]-N-[(1S)-1-formylpentyl]-4-methylpentanamide;KBioSS_000279;DTXSID70911457;ALLN, Ac-LLnL-CHO, MG-101, N-Acetyl-Leu-Leu-Norleu-al, N-Acetyl-L-leucyl-L-leucyl-L-norleucinal;DB07558;KBio3_000558;N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-L-leucinamide;Calpain Inhibitor I, N-Acetyl-Leu-Leu-norleucinal, synthetic;UPCMLD-DP120:001;N-{N-[N-Acetyl-(S)-leucyl]-(S)-leucyl}norleucinal;Calpain inhibitor I;Ac-LLnL-CHO;ALLN;2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE;110044-82-1;NCGC00161662-02;BRD-K35923252-001-01-0;CS-4961;SCHEMBL231491;EX-A3085;NCGC00161662-08;BSPBio_001559;(S)-2-acetamido-N-((S)-1-amino-4-methyl-1-oxopentan-2-yl)-4-methyl-N-((S)-1-oxohexan-2-yl)pentanamide;BDBM50069792;BS-48888;NCGC00161662-03;KBio2_005415;Calpain inhibitor I;n-acetyl-l-leucinyl-l-leucinyl-l-norleucinal;Ac-Leu-Leu-Nle-CHO;(2S)-2-[(2S)-2-ACETAMIDO-4-METHYLPENTANAMIDO]-4-METHYL-N-[(2S)-1-OXOHEXAN-2-YL]PENTANAMIDE;GTPL13381;Ac-LLnL-CHO;N-acetyl-Leu-Leu-norLeu-al;Ac-Leu-leu-nle-al
EINECS:
分子式:C20H37N3O4
分子量:383.52548
搜索质检报告(COA)
搜索MSDS